Eric Horwitz Named Acting Chairman of Radiation Oncology at Fox Chase Cancer Center
PHILADELPHIA (June 5, 2008)-Fox Chase Cancer Center has named Eric M. Horwitz, M.D., of Blue Bell, Pa., acting chairman of the department of radiation oncology. Horwitz, the department's vice chairman and clinical director, assumes the responsibilities on June 5.
Horwitz, who is nationally recognized for his expertise in treating patients with prostate cancer, replaces Alan Pollack, M.D., Ph.D., who accepted the role chairman of the radiation oncology department at the University of Miami after serving Fox Chase as chairman for seven years.
Since joining the staff in 1997, Horwitz's contributions include spearheading the clinical program as it grew exponentially in size and patient volumes. He developed advanced treatment programs using intensity-modulated radiation therapy (IMRT), image-guided radiation therapy and brachytherapy, including high-dose-rate (HDR) brachytherapy for prostate cancer. As a result, Fox Chase was the first in the northeastern United States to offer HDR implants to men with prostate cancer.
In addition, Horwitz integrated the use of an MRI treatment simulator into prostate cancer treatment planning for both permanent, low-dose prostate implants and external radiation therapy. Fox Chase was the first in the world to use MRI in radiation treatment planning. Horwitz currently oversees the department's third expansion in seven years which includes three new treatment facilities in the Cancer Research Pavilion being constructed on the Fox Chase campus
Horwitz has published extensively in peer-reviewed journals and is a co-author of several chapters in various oncology texts. He has been invited to give numerous lectures and presentations at professional meetings in the United States and abroad. Horwitz has been named a top doctor by Castle Connolly's "American's Top Doctors" and is annually listed as one of Philadelphia magazine's "Top Docs." He serves on the editorial board of the journal Brachytherapy and is vice president of the American Brachytherapy Society. He is also active in the American Society of Therapeutic Radiology and Oncology.
Horwitz received his M.D. from Albany College in New York after earning his undergraduate degree at the University of Pennsylvania in Philadelphia. He completed both his internship and residency at William Beaumont Hospital in Royal Oak, Mich., where he was chief resident in radiation oncology. Horwitz joined Fox Chase in 1997. In 2003, he was promoted from associate member to member with tenure in Fox Chase's division of medical science.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.